Substantial Funding to Develop the Global Human Microbiome Market From 2019-2027
“According to a new market research report published by Inkwood Research, the Global Human Microbiome Market is projected to rise at a CAGR of 22.41% throughout the forecasting years of 2019-2027.”
“Browse 64 market Data Tables and 52 Figures spread over 200 Pages, along with an in-depth TOC on Global Human Microbiome Market Forecast 2019-2027.”
Human Microbiome is a commercial approach to the life sciences sector. It is an aggregative term used for microbiotas like bacteria, fungi, viruses, etc., residing in a human body. The majority of microbiomes live in the gut and are generally anaerobic. The microbiome is anticipated to assist in the development of adequate medicines to treat multiple diseases. Human microbiome-based medicines and diagnostics have proved that exploiting the human metagenome can fill the gaps in the traditional treatment system. They co-evolve with humans and are crucial for human health and life. Microbiotas affect physiology, human development, immunity and nutrition. They assist in digestion, producing vitamins, and regulate immune systems. The global human microbiome market has attracted substantial investments from both private and public sectors.
Probiotics are Leading the Global Human Microbiome Market
Probiotics specialize in controlling the immune responses and providing essential nutrients at the same time to subdue the growth of infectious diseases. This limits its adoption in diseases like diarrhea and irritable bowel disease. However, it is increasingly adopted for conditions like obesity, diabetes, atopic immune disorders, etc. Probiotics are attracting notable investments by many companies globally.
To know more about this report, request a free sample copy.
Demand for Precision Medicine is Fueling the Human Microbiome Market
Precision medicine allows doctors to provide targeted treatment to patients. The diagnostic test helps the physician to know the effectiveness of a drug on the patients. It holds the ability to detect the disease at an early stage. The rising adoption of precision medicine is steering the growth of the human microbiome. Public and private organizations are investing subsequently in research and development of precision/personalized drugs.
North America is the Dominating Region of the Global Human Microbiome Market
Attractive funds and research grants from organizations for research and development of microbiome-based products are driving the growth of the market in this region. The United States holds the most significant share in the entire North American region. Moreover, the presence of giant market players that are continually investing in R&D for a new therapeutic area for the microbiome to eliminate health diseases like immune diseases, etc., is anticipated to pilot the demand for human microbiome in this region.
The global microbiome market is highly competitive. Hence, companies are consistently engaging in mergers, acquisitions, collaborations, and strategic partnerships to develop technologies, products, services, to sustain in the increasing rivalry. The prominent players of this market are Enterome Bioscience, Vedanta Bioscience, Second Genome, Microbiome Therapeutics LLC, and Enterologics.
About Inkwood Research
Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy; with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises of North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.